Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma

Anne Julia Klompenhouwer, Maaike Alblas, Belle Vivica van Rosmalen, Martinus Petrus Daniel Haring, Esmee Venema, Michail Doukas, Maarten Guillaume Josephus Thomeer, Robert Bart Takkenberg, Joanne Verheij, Vincent Erwin de Meijer, Thomas Matthijs van Gulik, Hester Floor Lingsma, Robert Auke de Man, Jan Nicolaas Maria Ijzermans

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

INTRODUCTION: Surgery is advocated in hepatocellular adenomas (HCA) >5 cm that do not regress to <5 cm after 6-12 months. The aim of this study was to develop a model for these patients, estimating the probability of HCA regression to <5 cm at 1 and 2 years follow-up. METHODS: Data were derived from a multicenter retrospective cohort of female patients diagnosed with HCA >5 cm at first follow-up. Potential predictors included age, body mass index, and HCA diameter at diagnosis (T0), HCA-subtype (hepatocyte nuclear factor 1α inactivated HCA, inflammatory-HCA, unclassified HCA) and "T0-T1 regression-over-time" (percentage of regression between T0 and first follow-up (T1) divided by weeks between T0 and T1). Cox proportional hazards regression was used to develop a multivariable model with time to regression of HCA < 5 cm as outcome. Probabilities at 1 and 2 years follow-up were calculated. RESULTS: In total, 180 female patients were included. Median HCA diameter at T0 was 82.0 mm and at T1 65.0 mm. Eighty-one patients (45%) reached the clinical endpoint of regression to <5 cm after a median of 34 months. No complications occurred during follow-up. In multivariable analysis, the strongest predictors for regression to <5 cm were HCA diameter at T0 (logtransformed, hazard ratio (HR) 0.05), T0-T1 regression-over-time (HR 2.15) and HCA subtype inflammatory-HCA (HR 2.93) and unclassified HCA (HR 2.40), compared to hepatocyte nuclear factor 1α inactivated HCA (reference). The model yielded an internally validated c-index of 0.79. DISCUSSION: In patients diagnosed with HCA > 5 cm that still exceed 5 cm at first follow-up, regression to <5 cm can be predicted at 1 and 2 years follow-up using this model. Although external validation in an independent population is required, this model may aid in decision-making and potentially avoid unnecessary surgery.
Original languageEnglish
Pages (from-to)1292-1298
JournalAmerican Journal of Gastroenterology
Volume114
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019
Externally publishedYes

Cite this